Abbott and Medtronic Partner to Expand Access to Advanced Diabetes Management Technologies

Collaboration to Enhance Patient Care with Continuous Glucose Monitoring and Automated Insulin Delivery

Abbott and Medtronic, two leading healthcare companies, have announced a global partnership to bring together their expertise in diabetes management and offer comprehensive solutions to improve patient care. This collaboration will provide patients with access to advanced tools and technologies that can help them manage their diabetes more effectively and efficiently.

Expanded Access to Continuous Glucose Monitoring (CGM)

Abbott will supply Medtronic with its continuous glucose monitoring (CGM) system, which will be integrated with Medtronic's smart dosing devices and software. This will give patients with diabetes a more comprehensive view of their glucose levels and enable them to make more informed insulin dosing decisions. The CGM will also provide real-time data to Medtronic's automated insulin delivery (AID) systems, further optimizing insulin therapy and improving glycemic control.

Enhanced Automated Insulin Delivery (AID) Systems

Medtronic's AID systems use algorithms to automatically adjust insulin delivery based on CGM data. This collaboration will allow Medtronic to incorporate Abbott's CGM into their AID systems, improving the accuracy and effectiveness of insulin delivery. The integrated system will provide patients with a more personalized and automated approach to diabetes management, reducing the burden of daily injections and improving overall outcomes.

Collaboration Benefits for Patients

The partnership between Abbott and Medtronic offers several benefits to patients with diabetes:

• Improved glycemic control and reduced risk of complications
• Increased convenience and reduced treatment burden
• Personalized and optimized insulin delivery
• Enhanced quality of life and well-being

Commitment to Innovation and Patient Care

Abbott and Medtronic share a commitment to innovation and improving the lives of people with diabetes. This partnership is a testament to their dedication to advancing diabetes management and developing solutions that empower patients to take control of their condition. By combining their expertise, Abbott and Medtronic aim to make a significant impact on the lives of millions of people living with diabetes around the world.